A modified form of a medication called niclosamide may hold the key to battling type 2 diabetes by reducing liver fat and improving insulin function. The research aims to find a safe and practical way to diminish fat content in the liver, which could safely treat patients of all weights.
Researchers at Georgia Institute of Technology have developed a new type of foam called capillary foam that solves many of the problems faced by traditional foams. This new foam is stable for months or years and can be made using a small amount of oil, expanding the range of particles useful for stabilizing foams.
A study published in Nature Geoscience found that air pollution, specifically aerosols, increases river flows in the northern hemisphere. The research reveals a significant impact of solar dimming on enhanced river flows over regions in heavily industrialised areas.
Scientists have identified a novel heart and gut disease, named Chronic Atrial Intestinal Dysrhythmia syndrome (CAID), caused by a rare genetic mutation. The disease is characterized by cardiac arrhythmias and intestinal pseudo-obstruction, with patients often requiring invasive treatments and surgeries.
A new web privacy system, COWL, protects users' data by confining malicious code, allowing flexible web development while improving surfing safety. The system will be freely available for download on October 15th.
A new study reveals that preosteoclasts, a previously overlooked group of cells, play a crucial role in maintaining bone health. The discovery explains the success of an experimental osteoporosis drug and opens up new avenues for research into designing future studies.
Researchers at Harvard University developed a barcoding tool to track the origin of blood cells, revealing that progenitor cells, not blood stem cells, give rise to specific blood cell types. This discovery challenges scientific dogma and has potential applications for blood regeneration therapies.
Researchers develop a novel antibiotic technique that uses the CRISPR enzyme to target specific DNA sequences in drug-resistant microbes, while leaving harmless bacteria intact. This approach shows promise in reducing the risk of secondary infections and preventing the spread of antibiotic resistance.
Researchers at the University of California, San Diego School of Medicine have discovered that T-cells are activated by a pain receptor called TRPV1 channel. The study shows that this receptor helps regulate intestinal inflammation in mice, suggesting a potential new target for treating certain autoimmune disorders.
A new crystallographic technique enables time-resolved crystallography, allowing researchers to study how molecular structures work. This breakthrough is expected to provide a major boost in areas of research that rely on understanding molecule function.
A study published in Nature Genetics has identified a fifth of the genetic factors that cause height to vary between individuals, doubling the number of known genome regions involved in height to more than 400. The research found that simple common genetic variation explains more than half of the factors involved in determining height.
Researchers at Imperial College London have taken pictures of the BRCA2 protein, showing how it repairs damaged DNA and interacts with other proteins. The study reveals that BRCA2 works in pairs with RAD51 to assemble filaments on broken DNA strands.
The largest genome-wide association study (GWAS) to date identifies over 400 gene regions influencing height, explaining about 20 percent of heritability. The study's findings prioritize many genes and pathways as important in skeletal growth during childhood, shedding light on the biology of height.